CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Mathew J. Kempton - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Mathew J. Kempton

OPENALEX: A5011077117↗ORCID: 0000-0003-3541-9947↗

Affiliations

Organizations

King's College Londonauthorship · GB

Public evidence

5 connected articles

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.2025 · Europe PMC Influence of cannabis use on incidence of psychosis in people at clinical high risk.2023 · Europe PMC Cannabis use in patients with early psychosis is associated with alterations in putamen and thalamic shape.2020 · PubMed Central Open Access Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis.2020 · PubMed Central Open Access The Maudsley environmental risk score for psychosis.2020 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.